The structure and functioning of signaling networks is complex, and they are differently deregulated in different contexts in non-trivial ways. To ensure efficiency of the drug treatments, a good knowledge of these complex interactions and how patient mutations affect the cellular fate is necessary. Among modeling techniques, logic modeling has proven to be very versatile and able to provide useful biological insights. Here, we show how to build a logic model from literature and experimental data and how to analyze the resulting model to obtain insights of relevance for systems pharmacology, using a prostate cancer example that involves some of the key phosphorylation pathways of this malignancy. We use data describing the phosphorylation r...
Discrete dynamical modeling shows promise in prioritizing drug combinations for screening efforts by...
Discrete dynamical modeling shows promise in prioritizing drug combinations for screening efforts by...
A major challenge in developing anticancer therapies is determining the efficacies of drugs and thei...
<p>The structure and functioning of signaling networks is complex, and they are differently deregula...
Here we present logic modeling as an approach to understand deregulation of signal transduction in d...
\u3cp\u3eHere we present logic modeling as an approach to understand deregulation of signal transduc...
We developed a logical model that considers major pathways responsible for prostate cancer developme...
The purpose of the project is to reconstruct Boolean models of signaling. Conventionally, large-scal...
ABSTRACT: Computational models are increasingly used to analyze the operation of complex biochemical...
Prostate cancer is the second most occurring cancer in men worldwide. To better understand the mecha...
Computational models are increasingly used to analyze the operation of complex biochemical networks,...
In the last few decades, extensive computational studies have been conducted on signaling pathways w...
Systems biology studies the structure and dynamics of biological systems using mathematical approach...
<p>The aim of this work is to build Boolean models to simulate specifically prostate cancer in indiv...
Treatment with combinations of drugs carries great promise for personalized therapy for a variety of...
Discrete dynamical modeling shows promise in prioritizing drug combinations for screening efforts by...
Discrete dynamical modeling shows promise in prioritizing drug combinations for screening efforts by...
A major challenge in developing anticancer therapies is determining the efficacies of drugs and thei...
<p>The structure and functioning of signaling networks is complex, and they are differently deregula...
Here we present logic modeling as an approach to understand deregulation of signal transduction in d...
\u3cp\u3eHere we present logic modeling as an approach to understand deregulation of signal transduc...
We developed a logical model that considers major pathways responsible for prostate cancer developme...
The purpose of the project is to reconstruct Boolean models of signaling. Conventionally, large-scal...
ABSTRACT: Computational models are increasingly used to analyze the operation of complex biochemical...
Prostate cancer is the second most occurring cancer in men worldwide. To better understand the mecha...
Computational models are increasingly used to analyze the operation of complex biochemical networks,...
In the last few decades, extensive computational studies have been conducted on signaling pathways w...
Systems biology studies the structure and dynamics of biological systems using mathematical approach...
<p>The aim of this work is to build Boolean models to simulate specifically prostate cancer in indiv...
Treatment with combinations of drugs carries great promise for personalized therapy for a variety of...
Discrete dynamical modeling shows promise in prioritizing drug combinations for screening efforts by...
Discrete dynamical modeling shows promise in prioritizing drug combinations for screening efforts by...
A major challenge in developing anticancer therapies is determining the efficacies of drugs and thei...